Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy

被引:15
作者
Ma, Kim [1 ]
Caplan, Stephen [1 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Div Hematol, Dept Med, 3755 Chemin Cote St Catherine,Room E-72, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1155/2016/9181698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Warm autoimmune hemolytic anemia (wAIHA) is the most common form of AIHA, with corticosteroids in first-line treatment resulting in a 60-80% response rate. Atypical wAIHA and IgG plus complement mediated disease have a higher treatment failure rate and higher recurrence rate. We report a case of severe wAIHA secondary to Waldenstrom macroglobulinemia with life threatening intravascular hemolysis refractory to prednisone, rituximab, splenectomy, and plasmapheresis. A four-week treatment of eculizumab in this heavily pretreated patient resulted in a sustained increase in hemoglobin and transfusion independence, suggesting a role for complement inhibition in refractory wAIHA.
引用
收藏
页数:3
相关论文
共 11 条
[1]   Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients [J].
Barcellini, Wilma ;
Fattizzo, Bruno ;
Zaninoni, Anna ;
Radice, Tommaso ;
Nichele, Ilaria ;
Di Bona, Eros ;
Lunghi, Monia ;
Tassinari, Cristina ;
Alfinito, Fiorella ;
Ferrari, Antonella ;
Leporace, Anna Paola ;
Niscola, Pasquale ;
Carpenedo, Monica ;
Boschetti, Carla ;
Revelli, Nicoletta ;
Villa, Maria Antonietta ;
Consonni, Dario ;
Scaramucci, Laura ;
De Fabritiis, Paolo ;
Tagariello, Giuseppe ;
Gaidano, Gianluca ;
Rodeghiero, Francesco ;
Cortelezzi, Agostino ;
Zanella, Alberto .
BLOOD, 2014, 124 (19) :2930-2936
[2]   Diagnosis and classification of autoimmune hemolytic anemia [J].
Bass, Garrett F. ;
Tuscano, Emily T. ;
Tuscano, Joseph M. .
AUTOIMMUNITY REVIEWS, 2014, 13 (4-5) :560-564
[3]   Autoimmune Manifestations in Patients With Waldenstrom Macroglobulinemia [J].
Bockorny, Bruno ;
Atienza, Jonessa A. ;
Dasanu, Constantin A. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (06) :456-459
[4]   Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab [J].
Chao, Mark P. ;
Hong, Jison ;
Kunder, Christian ;
Lester, Laura ;
Schrier, Stanley L. ;
Majeti, Ravindra .
AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (01) :78-81
[5]   Long-term response of refractory primary cold agglutinin disease to eculizumab therapy [J].
Gupta, Neha ;
Wang, Eunice S. .
ANNALS OF HEMATOLOGY, 2014, 93 (02) :343-344
[6]   Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria [J].
Hill, Anita ;
Rother, Russell P. ;
Wang, Xunde ;
Morris, Sidney M., Jr. ;
Quinn-Senger, Kerry ;
Kelly, Richard ;
Richards, Stephen J. ;
Bessler, Monica ;
Bell, Leonard ;
Hillmen, Peter ;
Gladwin, Mark T. .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) :414-425
[7]   How I treat autoimmune hemolytic anemias in adults [J].
Lechner, Klaus ;
Jaeger, Ulrich .
BLOOD, 2010, 116 (11) :1831-1838
[8]   Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome [J].
Legendre, C. M. ;
Licht, C. ;
Muus, P. ;
Greenbaum, L. A. ;
Babu, S. ;
Bedrosian, C. ;
Bingham, C. ;
Cohen, D. J. ;
Delmas, Y. ;
Douglas, K. ;
Eitner, F. ;
Feldkamp, T. ;
Fouque, D. ;
Furman, R. R. ;
Gaber, O. ;
Herthelius, M. ;
Hourmant, M. ;
Karpman, D. ;
Lebranchu, Y. ;
Mariat, C. ;
Menne, J. ;
Moulin, B. ;
Nuernberger, J. ;
Ogawa, M. ;
Remuzzi, G. ;
Richard, T. ;
Sberro-Soussan, R. ;
Severino, B. ;
Sheerin, N. S. ;
Trivelli, A. ;
Zimmerhackl, L. B. ;
Goodship, T. ;
Loirat, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23) :2169-2181
[9]   Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease [J].
Roeth, Alexander ;
Huettmann, Andreas ;
Rother, Russell P. ;
Duehrsen, Ulrich ;
Philipp, Thomas .
BLOOD, 2009, 113 (16) :3885-3886
[10]  
Roth A., 2015, P 57 ASH ANN M EXP A